Cover Image
市場調查報告書

全球嵌入式生醫材料市場

Global Markets for Implantable Biomaterials

出版商 BCC Research 商品編碼 321809
出版日期 內容資訊 英文 229 Pages
訂單完成後即時交付
價格
Back to Top
全球嵌入式生醫材料市場 Global Markets for Implantable Biomaterials
出版日期: 2015年01月01日 內容資訊: 英文 229 Pages
簡介

全球嵌入式生醫材料市場2013年幾乎達751億美金。該市場預計2014∼2019以複合成長率6.7%擴大,從2014年的791億美元成長到1,095億美元。

本報告提供全球嵌入式生醫材料市場概要與市場趨勢、至2019年的預測、各產品趨勢,及該產業的主要企業的總括簡介等彙整資料。

第1章 簡介

第2章 摘要

第3章 概要

  • 醫療所採用的生醫材料的分類
  • 合成生醫材料
  • 生物來源的生醫材料
  • 生醫材料的發展歷史
  • 生醫材料市場發展
  • 吸收性及侵蝕性生醫材料趨勢與技術的進步
  • 生醫材料技術的今後去向

第4章 全球嵌入式生醫材料市場

  • 簡介
  • 市場收益分析

第5章 北美市場

  • 法律規章必要條件
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 市場收益分析
  • 市場佔有率分析

第6章 歐洲市場

  • 法律規章必要條件
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 市場收益分析
  • 市場佔有率分析

第7章 亞太地區市場

第8章 南美市場

第9章 中東、非洲市場

第10章 企業簡介

  • AAP IMPLANTATE AG
  • AESCULAP AG & CO AG A DIVISION OF B. BRAUN MESUNGEN AG
  • ALCON (NOVARTIS)
  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAUMER S.A.
  • BAUSCH & LOMB INC. (VALEANT PHARMACEUTICALS INTERNATIONAL INC.)
  • BERKELEY ADVANCED BIOMATERIALS INC.
  • BIOMET INC.
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COLLAGEN MATRIX INC.
  • THE COOK GROUP
  • CORBION PURAC
  • CORDIS CORP. (JOHNSON & JOHNSON)
  • CORIN GROUP PLC
  • COVIDIEN LTD.
  • C.R. BARD INC.
  • DEPUY SYNTHES (JOHNSON & JOHNSON)
  • EDWARDS LIFESCIENCES CORP.
  • ETHICON INC. AND ETHICON ENDO-SURGERY INC. (JOHNSON & JOHNSON)
  • EXACTECH, INC.
  • FZIOMED INC.
  • INTEGRA LIFESCIENCES CORP.
  • INVIBIO BIOMATERIALS SOLUTIONS
  • 京瓷醫學株式會社
  • LIFECELL CORP.
  • MEDTRONIC
  • NOBEL BIOCARE
  • NOVABONE PRODUCTS
  • ORGANOGENESIS INC.
  • ROYAL DSM N.V.
  • SMITH & NEPHEW
  • SORIN GROUP
  • ST. JUDE MEDICAL
  • STRAUMANN
  • STRYKER INC.
  • TORNIER N.V.
  • TUTOGEN MEDICAL GMBH
  • VASCUTEK, A TERUMO CO.
  • W.L. GORE & ASSOCIATES INC.
  • WRIGHT MEDICAL GROUP, INC.
  • ZIMMER HOLDINGS INC.

第11章 附錄A:企業聯絡處

第12章 附錄B:簡稱說明

圖表

目錄
Product Code: AVM118A

The global market for implantable biomaterials in 2013 was worth nearly $75.1 billion. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019. This will result in $79.1 billion in 2014 and $109.5 billion global market in 2019.

This report provides: An overview of the global market for biomaterials used in medical applications. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019. Segmentation of the biomaterials based on the materials from which they are made including metallic, ceramic, polymeric, natural and composite materials. Segmentation based on therapeutic or application area including orthopaedic, cardiovascular, dental, immunology and infection, pulmonary/respiratory disease, plastic surgery, ophthalmology, oncology, neurology, and more. Comprehensive profiles of leading companies in the industry.

image1

REPORT SCOPE

SCOPE OF THE REPORT

This market research report focuses on the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion and analysis of the application of biomaterials and a review of new and developing technology platforms. This report also examines companies that are actively developing and marketing medical biomaterials around the world. Detailed tables and charts with sales forecasts and market share data are also included.

Products that are used as biomaterials can be segmented by the materials from which they are made; for example:

  • Metallic.
  • Ceramic.
  • Polymeric.
  • Natural.
  • Composites.

In addition to the segmentation by material type, medical biomaterials can also be examined by application/therapeutic area as follows:

  • Orthopedic.
  • Cardiovascular.
  • Dental.
  • Immunology and infection.
  • Pulmonary/respiratory disease.
  • Plastic surgery.
  • Urology/gynecology.
  • Endocrinology and metabolic diseases.
  • Ophthalmology.
  • Oncology.
  • Dermatology and wound care.
  • Gastroenterology.
  • Neurology.
  • Oto-Rhino-Laryngology (ORL).

The global market for medical biomaterials has been estimated at $48 billion in 2013, and is expected to more than double by 2019, reaching $102.5 billion. The growth represents a compound annual growth rate (CAGR) of by the end of the forecast period.

In 2013, the cardiovascular biomaterial segment represented the largest single market segment, accounting for 34.5% of the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to experience the highest growth in the coming years. North America is the largest market for biomaterials and is expected to grow at CAGR of 5.2% from 2014 to 2019 due to an increase in the aging population.

Due to rising awareness of biomaterial products in Asia, and increased partnerships and collaborations, the Asian market is expected to grow at a CAGR of 21.5% from 2014 to 2019.

ANALYST'S CREDENTIALS

The author is an independent market analyst for the medical industry with a BSc and PhD in Biochemistry from the University of Liverpool and an MBA from Oxford Brookes University. The author worked in the medical industry as a senior marketing executive for 20 years, creating and implementing strategic business and marketing plans for major multinational medical device companies before establishing himself as an independent research analyst.

For the last 15 years, the author has worked extensively in managing and conducting market research projects in key healthcare markets to determine market conditions, product attributes, issues and opinions. This data and information has been used to analyze specific product global market segments, and to create and implement strategic business and marketing plans for major multinational companies to launch new products and product line extensions, as well as to re-market existing product lines.

The author has also acquired knowledge and experience with a wide range of software applications including predictive analytical software such as SPSS, Stata and SAS as a means of obtaining logistic regression, statistical variance analysis and mixed model analysis of market research data. This form of analysis has been used recently to prepare a variety of customized strategic marketing plans for individual clients in the biopharmaceutical and biotechnology industries.

Table of Contents

CHAPTER 1 INTRODUCTION

  • INTRODUCTION
  • STUDY GOALS AND OBJECTIVES
  • SCOPE OF THE REPORT
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 SUMMARY

  • SUMMARY TABLE GLOBAL REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)

CHAPTER 3 OVERVIEW

  • CLASSIFICATION OF BIOMATERIALS USED IN MEDICINE
  • FIGURE 1 CLASSIFICATION OF BIOMATERIALS
    • NATURAL BIOMATERIALS
    • SYNTHETIC BIOMATERIALS
    • COMBINED BIOMATERIALS
  • SYNTHETIC BIOMATERIALS
    • POLYMER BIOMATERIALS
      • Synthetic Polymeric Materials
      • TABLE 1 FDA LIST OF THERMOPLASTIC, THERMOSET/ELASTOMER AND ABSORBABLE BIOMATERIALS
      • Synthetic Non-Biodegradable Polymers
      • TABLE 2 FDA LIST OF ADHESIVE AND FLUID BIOMATERIALS
        • Ultra-high-Molecular-Weight Polyethylene
        • Polyetheretherketone (PEEK)
        • Polymethyl Methacrylate
        • TABLE 3 BONE CEMENT COMPONENTS
        • Polyethylene Terephthalate
        • Polytetrafluoroethylene
      • Synthetic Biodegradable Polymers
      • Hydrogels
    • METALLIC BIOMATERIAL ALLOYS AND TECHNOLOGIES
      • Stainless Steel
      • TABLE 4 FDA GENERAL CLASSIFICATION OF METALLIC BIOMATERIALS COMPENDIUM
      • Cobalt Chromium Alloys
      • Titanium and Titanium Alloys
      • Shape Memory Metal (Nickel-Titanium Alloy (NiTi)
      • New Alloys
      • Modifying Compatibility and Functionality through Surface Modification
      • Recent Advances in Material Technology for Orthopedic Surgery
        • Electrospinning Nanofibers
        • "Superfinishing" of Implant Surfaces Using Micro Machine Processing
        • Electrophoretic Deposition (EPD) of Hydroxyapatite or Bioactive Glass C
        • Metallic Alloys and Technologies
    • CERAMIC BIOMATERIALS
    • TABLE 5 FDA GENERAL CLASSIFICATION OF CERAMIC AND COMPOSITE CERAMIC BIOMATERIALS COMPENDIUM
      • Bioinert Ceramics
      • Bioactive Ceramics
        • Hydroxylapatite
        • Tricalcium Phosphate (TCP)
      • Ceramic on Ceramic Bearings
    • COMPOSITE BIOMATERIALS
    • TABLE 6 FDA GENERAL CLASSIFICATION OF COMPOSITE BIOMATERIALS COMPENDIUM
  • BIOMATERIALS OF BIOLOGICAL ORIGIN
  • FIGURE 7 GLOBAL REVENUE SHARES OF ORTHOPEDICS BIOMATERIALS BY REGION, 2013 (%)
  • HISTORICAL DEVELOPMENT OF BIOMATERIALS
  • BIOMATERIALS MARKET EVOLUTION
  • FIGURE 2 CLASSIFICATION OF BIOMATERIALS
    • HISTORY AND DEVELOPMENT OF ABSORBABLE AND ERODIBLE WOUND CLOSURE BIOMATERIALS
      • Sutures
      • FIGURE 3 MARKET DYNAMICS BY THERAPEUTIC AREA
      • Surgical Glues
    • HISTORY AND DEVELOPMENT OF ABSORBABLE AND ERODIBLE ORTHOPEDIC BIOMATERIALS
  • RECENT DEVELOPMENTS AND TECHNOLOGICAL ADVANCES IN ABSORBABLE AND ERODIBLE BIOMATERIALS
    • ABSORBABLE AND ERODIBLE WOUND CLOSURE BIOMATERIALS
      • Developments into Control of Absorption or Degradation Rates for Absorbable Sutures
      • Development of Second-Generation Fibrin Sealants
      • Research into and Development of Bioabsorbables for Reduction of Post-Operative Adhesions
    • ABSORBABLE AND ERODIBLE ORTHOPEDIC BIOMATERIALS 4
      • Continued R&D into Recombinant Human Osteogenic Protein-1 (rhOP-1)
  • ONGOING AND FUTURE DEVELOPMENTS IN BIOMATERIAL TECHNOLOGIES
    • DEVELOPMENTS IN FIBER-BASED TISSUE ENGINEERING TECHNOLOGIES (FBTE)
      • Electrospinning Nanofibers
      • Thermally Induced Phase Separation
      • 3-D Fiber-Deposited Scaffolds for Tissue Engineering and Organ Printing
      • Self-Assembling Tissue Engineering Systems
    • "SUPERFINISHING" OF IMPLANT SURFACES USING MMP
    • ELECTROPHORETIC DEPOSITION OF HYDROXYAPATITE OR BIOACTIVE GLASS
    • METALLIC ALLOYS AND TECHNOLOGIES
    • STEM CELL TECHNOLOGIES AND NANOENGINEERED BIOMATERIALS
    • DEVELOPMENTS IN CERAMIC TECHNOLOGIES
    • DEVELOPMENTS IN SMART POLYMERS AS BIOMATERIALS
    • EXAMPLES OF PROPRIETARY BIOMATERIAL TECHNOLOGIES
      • Dyneema Purity Fiber
      • Small Intestinal Submucosa Technology
      • Biomaterial-Based Platform Technology

CHAPTER 4 GLOBAL IMPLANTABLE BIOMATERIALS MARKET

  • INTRODUCTION
  • MARKET REVENUE ANALYSIS
    • GLOBAL MARKET REVENUE ANALYSIS
    • TABLE 8 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 4 GLOBAL MARKET FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
      • Global Market Revenue Analysis by Region
      • FIGURE 5 GLOBAL REVENUES FOR IMPLANTABLE BIOMATERIALS BY REGION, 2014 (%)
      • Global Market Revenue Analysis by Market Segment
      • TABLE 9 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
      • FIGURE 6 GLOBAL REVENUES FOR IMPLANTABLE BIOMATERIALS BY INDIVIDUAL SEGMENT, 2013 ($ MILLIONS)
      • TABLE 10 GLOBAL REVENUE FORECAST FOR BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • FIGURE 7 GLOBAL REVENUE SHARES OF ORTHOPEDICS BIOMATERIALS BY REGION, 2013 (%)
      • FIGURE 8 GLOBAL REVENUES FOR CARDIOVASCULAR BIOMATERIALS BY REGION, 2013 (%)
      • TABLE 11 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 12 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 13 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 14 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 15 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)

CHAPTER 5 NORTH AMERICAN MARKET FOR IMPLANTABLE BIOMATERIALS 61

  • REGULATORY AND LEGISLATIVE REQUIREMENTS
    • UNITED STATES
      • FDA Medical Device Regulations
      • Regulatory Approval Process for Biomaterials
      • Centers for Medicare & Medicaid Services
      • The 2010 Affordable Care Act
      • Private Insurance
        • Traditional Fee-for-Service Health Insurance Plans
        • Health Maintenance Organizations (HMOs)
        • Preferred Provider Organizations (PPOs)
        • FIGURE 9 PRIVATE HEALTH INSURANCE COVERAGE IN THE U.S. AMONG PERSONS UNDER AGE 65, 2007-2011 (MILLION/%)
        • TABLE 16 PERSONAL HEALTHCARE EXPENDITURES; AGGREGATE AND PER CAPITA AMOUNTS, PERCENT DISTRIBUTION AND ANNUAL PERCENTAGE CHANGE BY SOURCE OF FUNDS, 2006-2018 ($ BILLIONS)
    • CANADA
  • MARKET DYNAMICS
    • MARKET DRIVERS
      • Aging Population Principal Driver of Biomaterials in the European Market
      • Advances in Surgical Techniques, Material Sciences, Multiple Design Options and Manufacturing Processes Continue to Help Stimulate Market Development
      • Potential Market Opportunities for Use of Antimicrobial Biomaterials in the U.S.
      • Opportunities for Biomaterial Use in Drug Delivery Systems Using Microneedles
    • MARKET RESTRAINTS
      • Cost Containment Issues Restrain Growth and Development of the Implant Industry
        • Concerns over Cost Issues Relating to Drug-Eluting Stents
        • Continuing Fears and Concerns over Late Stent Thrombosis Restrain Development of North American Market
  • MARKET REVENUE ANALYSIS
    • NORTH AMERICAN MARKET REVENUE ANALYSIS
      • North American Market Revenue Analysis
      • TABLE 17 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
      • FIGURE 10 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
      • North American Market Revenue Analysis by Country
      • TABLE 18 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
      • North American Market Revenue Analysis by Market Segment
      • TABLE 19 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
      • FIGURE 11 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
      • TABLE 20 NORTH AMERICAN REVENUE FORECAST FOR ORTHOPEDICS AND CARDIOVASCULAR BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
      • TABLE 21 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 22 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 23 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 24 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 25 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE ANALYSIS
    • NORTH AMERICAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
    • TABLE 26 NORTH AMERICAN MARKET SHARE ANALYSIS OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 27 NORTH AMERICAN MARKET SHARE ANALYSIS OF ORTHOPEDIC BIOMATERIALS BY COMPANY, 2013
    • TABLE 28 NORTH AMERICAN MARKET SHARE ANALYSIS OF CARDIOVASCULAR BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)

CHAPTER 6 EUROPEAN MARKET FOR IMPLANTABLE BIOMATERIALS 8

  • REGULATORY AND LEGISLATIVE REQUIREMENTS
    • (GENERAL) MEDICAL DEVICE DIRECTIVE, MDD (93/42/EEC)
    • ACTIVE IMPLANTABLE MEDICAL DEVICE DIRECTIVE, AIMDD (90/383/EEC)
    • IN VITRO DIAGNOSTIC MEDICAL DEVICE DIRECTIVE, IVDMDD (98/79/EC)
      • PIP Breast Implants
      • MoM Hip Implants
    • PROPOSAL FOR CHANGES TO THE MEDICAL DEVICE DIRECTIVE, MDD (93/42/EEC)
    • THE RUSSIAN FEDERATION
  • MARKET DYNAMICS
    • MARKET DRIVERS
      • Technological Advances in Materials, Operative Procedures, Product Design and Manufacturing Processes Help Stimulate Market Development
      • Growth and Development of Biomaterials for Use in Ophthalmics 9
      • Growth and Development of Biomaterials for Use in Dentistry
    • MARKET RESTRAINTS
      • Influence and Impact of the National Joint Registries on the Joint Replacement Market
      • Impact of the PIP Breast Implant Scandal on the European Breast Implant Market
      • Increased Competitive Product Pricing and Mandatory Tendering Regarded as a Major Market Restraint
  • MARKET REVENUE ANALYSIS
    • EUROPEAN MARKET REVENUE ANALYSIS
    • TABLE 29 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 12 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
    • European Market Revenue Analysis by Country
    • TABLE 30 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 31 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (FRANCE AND GERMANY), THROUGH 2019 ($ MILLIONS)
    • TABLE 32 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (ITALY AND SPAIN), THROUGH 2019 ($ MILLIONS)
    • TABLE 33 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (UNITED KINGDOM AND BENELUX), THROUGH 2019 ($ MILLIONS)
    • European Market Revenue Analysis by Market Segment
    • TABLE 34 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
    • FIGURE 13 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
    • TABLE 35 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • TABLE 36 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • TABLE 37 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • TABLE 38 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • TABLE 39 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • TABLE 40 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
    • MARKET SHARE ANALYSIS
    • EUROPEAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
    • TABLE 41 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 42 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS BY COMPANY, 2013
    • TABLE 43 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)

CHAPTER 7 ASIA-PACIFIC MARKET FOR IMPLANTABLE BIOMATERIALS

  • JAPAN
    • REGULATORY AND LEGISLATIVE REQUIREMENTS
    • TABLE 44 OVERVIEW OF PHARMACEUTICAL AFFAIRS LAW (PAL) AND JAPANESE MEDICAL DEVICES NOMENCLATURE (JMDN) CODES AND RELATED CODES ACCORDING TO THE EU MDD
      • Marketing Authorization System
      • TABLE 45 REIMBURSEMENT CATEGORIES IN JAPAN
  • CHINA
    • OVERVIEW OF THE HEALTHCARE SYSTEM
    • FIGURE 14 THE CHINESE HEALTHCARE SYSTEM
    • HEALTHCARE REFORMS
      • New Rural Co-operative Medical Care System
      • Urban Residents Healthcare Insurance Scheme
    • HEALTHCARE INSTITUTIONS
    • TABLE 46 NUMBER OF HEALTHCARE INSTITUTIONS, ACCORDING TO OWNERSHIP IN CHINA, 2010 (NUMBER)
    • HOSPITAL RESOURCES
    • TABLE 47 TOTAL NUMBER OF HOSPITALS IN CHINA BY RANKING, 2010
  • INDIA
    • OVERVIEW OF THE HEALTHCARE SYSTEM
      • National Level
      • State Level
      • Regional Level
      • District Level
      • Sub-divisional/Taluka Level
      • Community Level
      • Primary Health Centers Level
      • Sub Health Center (SHC) Level
      • TABLE 48 OVERVIEW OF HEALTHCARE IN INDIA
    • HOSPITAL RESOURCES
    • POPULATION STATISTICS
  • SOUTH KOREA
  • MARKET DYNAMICS
    • MARKET DRIVERS
      • Booming Economies in Emerging Markets
      • Westernized Lifestyle Increases Cardiovascular Problems in the Asia-Pacific Region
      • Initiatives to Improve Dental Care in India
      • Growth in the Indian Market
        • Growing Population
        • Affluent Consumers
        • Health Expenditure
        • Lifestyle-Related Disorders Drive Demand
      • Resilient to the Recession
    • MARKET RESTRAINTS
      • China
      • Increased Involvement of Local Medical Device Companies
      • Lack of Penetration to Rural Parts of China
      • Complex Legislative and Regulatory Rules
        • Distribution
        • Distribution is Very Fragmented
        • Chinese Distributors Are Difficult to Manage
        • Relationships Are Key to Distribution
        • Limited Capability to Successfully Develop the Market
      • India
        • Inadequacies of India's Healthcare Infrastructure
        • Widespread Lack of Health Insurance
        • Lack of Access to Healthcare Services
      • Japan
      • MARKET REVENUE ANALYSIS
    • ASIA-PACIFIC: MARKET REVENUE ANALYSIS
    • TABLE 49 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 15 ASIA-PACIFIC REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
      • Asia-Pacific: Market Revenue Analysis by Country
      • TABLE 50 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
      • TABLE 51 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (CHINA AND JAPAN), THROUGH 2019 ($ MILLIONS)
      • TABLE 52 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (INDIA AND SOUTH KOREA), THROUGH 2019 ($ MILLIONS)
      • Asia-Pacific: Market Revenue Analysis by Market Segment
      • TABLE 53 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
      • FIGURE 16 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY INDIVIDUAL SEGMENT, 2013 ($ MILLIONS)
      • TABLE 54 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 55 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 56 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 57 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 58 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 59 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE ANALYSIS
    • ASIA-PACIFIC MARKET SHARE ANALYSIS BY MARKET SEGMENT
    • TABLE 60 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013
    • TABLE 61 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 62 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ BILLIONS/%)

CHAPTER 8 LATIN AMERICAN MARKET FOR IMPLANTABLE BIOMATERIALS

  • BRAZIL
    • BACKGROUND
      • Regulatory and Legislative Requirements
      • Market Entry and Reimbursement of Medical Devices: Brazil
  • ARGENTINA
    • BACKGROUND
      • Government-Funded Public Health Sector
      • Social Health Insurance Sector
      • Private Sector
      • Regulatory and Legislative Requirements
  • MEXICO
    • BACKGROUND
      • Legislation and Regulations Governing Medical Devices in Mexico
      • Health Insurance Structure Mexico
  • MARKET DYNAMICS
    • MARKET DRIVERS
      • Market Growth Opportunities in Brazil
        • Growth in Private Healthcare and Private Insurance Plans
        • Expansion and Modernization of Top Private Hospitals
        • Largest and Fastest-Growing Medical Device Market in Latin America
        • Government Support to Boost Brazil's Healthcare Sector
      • Expansion of Healthcare Opportunities in Mexico
      • Introduction of Tax-Funded Universal Health Coverage throughout Latin America
      • Anticipated Increase in the Burden of Cardiovascular Disease in Central and Latin America
    • MARKET RESTRAINTS
      • Diverse Regulatory Environment Constrains Latin American Medical Device Market
      • Challenges Associated with Local Business Practices and Cultural Conditions in Brazil
      • Issues Associated with the Distribution of Medical Devices in Latin America
      • Pricing Issues
  • MARKET REVENUE ANALYSIS
    • LATIN AMERICAN MARKET REVENUE ANALYSIS
    • TABLE 63 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 17 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2029 ($ MILLIONS)
      • Latin American Market Revenue Analysis by Country
      • TABLE 64 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
      • TABLE 65 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (ARGENTINA AND BRAZIL), THROUGH 2019 ($ MILLIONS)
      • TABLE 66 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (CHILE AND MEXICO), THROUGH 2019 ($ MILLIONS)
      • Latin American Market Revenue Analysis by Market Segment
      • TABLE 67 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
      • FIGURE 18 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
      • TABLE 68 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 69 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 70 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 71 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 72 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 73 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE ANALYSIS
    • LATIN AMERICAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
    • TABLE 74 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 75 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDIC APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
    • TABLE 76 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)

CHAPTER 9 MIDDLE EASTERN/AFRICAN MARKET FOR IMPLANTABLE BIOMATERIALS

  • INTRODUCTION
  • SOUTH AFRICA
    • REGIONAL REGULATIONS, LEGISLATION AND REIMBURSEMENT: MIDDLE EAST/AFRICA
    • SOUTH AFRICAN MEDICAL DEVICE REGULATORY REQUIREMENTS
    • HEALTH INSURANCE STRUCTURE: SOUTH AFRICA
    • REIMBURSEMENT OF MEDICAL DEVICES: SOUTH AFRICA
  • SAUDI ARABIA
    • PUBLIC HEALTHCARE SYSTEM
      • Primary Healthcare Services
      • Secondary and Tertiary Healthcare Services
      • FIGURE 19 STRUCTURE OF THE HEALTHCARE SECTOR IN SAUDI ARABIA, 2012
      • FIGURE 20 NUMBER OF HOSPITALS IN SAUDI ARABIA BY SUPPLIER, 2012
      • Private Healthcare Sector
      • Medical Device Regulatory Requirements: Saudi Arabia
      • Health Insurance Structure: Saudi Arabia
  • MARKET DYNAMICS
    • MARKET DRIVERS
      • Encouraging Signs that Africa's Medical Device Market is Growing
      • Substantial Financial Support for Healthcare in Saudi Arabia
      • South Africa's Political Stability and Improved Economic Outlook Help Support Growth in Healthcare Market
      • Improved Financial Factors Help Introduction of Cardiac Catheterization Procedures in African Countries
    • MARKET RESTRAINTS
      • Manual Compression will Remain Principal Method of Vascular Closure in Africa
      • Relatively Poorly Regulated and Low Level of Training/Education of Interventional Cardiologists in Africa
      • Poor Distribution Structure and Networks in Africa
      • Medical Tourism to India for African Patient Requiring Angioplasty Procedures
  • MARKET REVENUE ANALYSIS
    • MIDDLE/EAST AFRICAN MARKET REVENUE ANALYSIS
    • TABLE 77 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
    • FIGURE 21 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
    • Middle East/African Market Revenue Analysis by Country
    • TABLE 78 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
    • TABLE 79 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
      • Middle East/African Market Revenue Analysis by Market Segment
      • TABLE 80 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 81 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 82 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
      • TABLE 83 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 84 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
      • TABLE 85 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE ANALYSIS
    • MIDDLE EAST/AFRICAN MARKET SHARE ANALYSIS BY MARKET SEGMENT
    • TABLE 86 MIDDLE EAST/AFRICAN MARKET SHARE ANALYSIS OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013
    • TABLE 87 MIDDLE EAST/AFRICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDIC APPLICATIONS BY COMPANY, 2013
    • TABLE 88 MIDDLE EAST/AFRICA MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013

CHAPTER 10 COMPANY PROFILES

  • AAP IMPLANTATE AG
  • AESCULAP AG & CO AG A DIVISION OF B. BRAUN MESUNGEN AG
  • ALCON (NOVARTIS)
  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BAUMER S.A.
  • BAUSCH & LOMB INC. (VALEANT PHARMACEUTICALS INTERNATIONAL INC.)
  • BERKELEY ADVANCED BIOMATERIALS INC.
  • BIOMET INC.
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COLLAGEN MATRIX INC.
  • THE COOK GROUP
  • CORBION PURAC
  • CORDIS CORP. (JOHNSON & JOHNSON)
  • CORIN GROUP PLC
  • COVIDIEN LTD.
  • C.R. BARD INC.
  • DEPUY SYNTHES (JOHNSON & JOHNSON)
  • EDWARDS LIFESCIENCES CORP.
  • ETHICON INC. AND ETHICON ENDO-SURGERY INC. (JOHNSON & JOHNSON)
  • EXACTECH, INC.
  • FZIOMED INC.
  • INTEGRA LIFESCIENCES CORP.
  • INVIBIO BIOMATERIALS SOLUTIONS
  • KYOCERA MEDICAL CORP.
  • LIFECELL CORP.
  • MEDTRONIC
  • NOBEL BIOCARE
  • NOVABONE PRODUCTS
  • ORGANOGENESIS INC.
  • ROYAL DSM N.V.
  • SMITH & NEPHEW
  • SORIN GROUP
  • ST. JUDE MEDICAL
  • STRAUMANN
  • STRYKER INC.
  • TORNIER N.V.
  • TUTOGEN MEDICAL GMBH
  • VASCUTEK, A TERUMO CO.
  • W.L. GORE & ASSOCIATES INC.
  • WRIGHT MEDICAL GROUP, INC.
  • ZIMMER HOLDINGS INC.

CHAPTER 11 APPENDIX A: COMPANY CONTACT DETAILS

CHAPTER 12 APPENDIX B: ACRONYMS

LIST OF TABLES

  • SUMMARY TABLE GLOBAL REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 1 FDA LIST OF THERMOPLASTIC, THERMOSET/ELASTOMER AND ABSORBABLE BIOMATERIALS
  • TABLE 2 FDA LIST OF ADHESIVE AND FLUID BIOMATERIALS
  • TABLE 3 BONE CEMENT COMPONENTS
  • TABLE 4 FDA GENERAL CLASSIFICATION OF METALLIC BIOMATERIALS COMPENDIUM
  • TABLE 5 FDA GENERAL CLASSIFICATION OF CERAMIC AND COMPOSITE CERAMIC BIOMATERIALS COMPENDIUM
  • TABLE 6 FDA GENERAL CLASSIFICATION OF COMPOSITE BIOMATERIALS COMPENDIUM
  • TABLE 8 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 9 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 10 GLOBAL REVENUE FORECAST FOR BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 11 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 12 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 13 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 14 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 15 GLOBAL REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 16 PERSONAL HEALTHCARE EXPENDITURES; AGGREGATE AND PER CAPITA AMOUNTS, PERCENT DISTRIBUTION AND ANNUAL PERCENTAGE CHANGE BY SOURCE OF FUNDS, 2006-2018 ($ BILLIONS)
  • TABLE 17 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 18 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • TABLE 19 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 20 NORTH AMERICAN REVENUE FORECAST FOR ORTHOPEDICS AND CARDIOVASCULAR BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 21 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 22 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 23 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 24 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 25 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 26 NORTH AMERICAN MARKET SHARE ANALYSIS OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%) 8
  • TABLE 27 NORTH AMERICAN MARKET SHARE ANALYSIS OF ORTHOPEDIC BIOMATERIALS BY COMPANY, 2013
  • TABLE 28 NORTH AMERICAN MARKET SHARE ANALYSIS OF CARDIOVASCULAR BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 29 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 30 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • TABLE 31 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (FRANCE AND GERMANY), THROUGH 2019 ($ MILLIONS)
  • TABLE 32 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (ITALY AND SPAIN), THROUGH 2019 ($ MILLIONS)
  • TABLE 33 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (UNITED KINGDOM AND BENELUX), THROUGH 2019 ($ MILLIONS)
  • TABLE 34 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 35 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 36 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 37 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 38 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 39 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 40 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 41 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 42 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS BY COMPANY, 2013
  • TABLE 43 EUROPEAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 44 OVERVIEW OF PHARMACEUTICAL AFFAIRS LAW (PAL) AND JAPANESE MEDICAL DEVICES NOMENCLATURE (JMDN) CODES AND RELATED CODES ACCORDING TO THE EU MDD
  • TABLE 45 REIMBURSEMENT CATEGORIES IN JAPAN
  • TABLE 46 NUMBER OF HEALTHCARE INSTITUTIONS, ACCORDING TO OWNERSHIP IN CHINA, 2010 (NUMBER)
  • TABLE 47 TOTAL NUMBER OF HOSPITALS IN CHINA BY RANKING, 2010
  • TABLE 48 OVERVIEW OF HEALTHCARE IN INDIA
  • TABLE 49 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 50 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • TABLE 51 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (CHINA AND JAPAN), THROUGH 2019 ($ MILLIONS)
  • TABLE 52 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (INDIA AND SOUTH KOREA), THROUGH 2019 ($ MILLIONS)
  • TABLE 53 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 54 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 55 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 56 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 57 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 58 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 59 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 60 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013
  • TABLE 61 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 62 ASIA-PACIFIC MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ BILLIONS/%)
  • TABLE 63 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 64 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • TABLE 65 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (ARGENTINA AND BRAZIL), THROUGH 2019 ($ MILLIONS)
  • TABLE 66 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY (CHILE AND MEXICO), THROUGH 2019 ($ MILLIONS)
  • TABLE 67 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, THROUGH 2019 ($ MILLIONS)
  • TABLE 68 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 69 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 70 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN PULMONARY AND PLASTIC SURGERY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 71 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 72 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 73 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 74 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 75 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDIC APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 76 LATIN AMERICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013 ($ MILLIONS/%)
  • TABLE 77 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 78 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • TABLE 79 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY COUNTRY, THROUGH 2019 ($ MILLIONS)
  • TABLE 80 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDICS AND CARDIOVASCULAR APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 81 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DENTAL SURGERY AND IMMUNOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 82 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, THROUGH 2019 ($ MILLIONS)
  • TABLE 83 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN UROLOGY/GYNECOLOGY AND ENDOCRINOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 84 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN OPHTHALMICS AND ONCOLOGY APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 85 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS USED IN DERMATOLOGY AND OTHER SURGICAL APPLICATIONS, THROUGH 2019 ($ MILLIONS)
  • TABLE 86 MIDDLE EAST/AFRICAN MARKET SHARE ANALYSIS OF IMPLANTABLE BIOMATERIALS BY COMPANY, 2013
  • TABLE 87 MIDDLE EAST/AFRICAN MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN ORTHOPEDIC APPLICATIONS BY COMPANY, 2013
  • TABLE 88 MIDDLE EAST/AFRICA MARKET SHARES OF IMPLANTABLE BIOMATERIALS USED IN CARDIOVASCULAR APPLICATIONS BY COMPANY, 2013

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
  • FIGURE 1 CLASSIFICATION OF BIOMATERIALS 1
  • FIGURE 7 GLOBAL REVENUE SHARES OF ORTHOPEDICS BIOMATERIALS BY REGION, 2013 (%)
  • FIGURE 2 CLASSIFICATION OF BIOMATERIALS
  • FIGURE 3 MARKET DYNAMICS BY THERAPEUTIC AREA
  • FIGURE 4 GLOBAL MARKET FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
  • FIGURE 5 GLOBAL REVENUES FOR IMPLANTABLE BIOMATERIALS BY REGION, 2014 (%)
  • FIGURE 6 GLOBAL REVENUES FOR IMPLANTABLE BIOMATERIALS BY INDIVIDUAL SEGMENT, 2013 ($ MILLIONS)
  • FIGURE 7 GLOBAL REVENUE SHARES OF ORTHOPEDICS BIOMATERIALS BY REGION, 2013 (%)
  • FIGURE 8 GLOBAL REVENUES FOR CARDIOVASCULAR BIOMATERIALS BY REGION, 2013 (%)
  • FIGURE 9 PRIVATE HEALTH INSURANCE COVERAGE IN THE U.S. AMONG PERSONS UNDER AGE 65, 2007-2011 (MILLION/%)
  • FIGURE 10 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
  • FIGURE 11 NORTH AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
  • FIGURE 12 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
  • FIGURE 13 EUROPEAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
  • FIGURE 14 THE CHINESE HEALTHCARE SYSTEM
  • FIGURE 15 ASIA-PACIFIC REVENUE FORECASTS FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
  • FIGURE 16 ASIA-PACIFIC REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY INDIVIDUAL SEGMENT, 2013 ($ MILLIONS)
  • FIGURE 17 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2029 ($ MILLIONS)
  • FIGURE 18 LATIN AMERICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS BY SEGMENT, 2013 ($ MILLIONS)
  • FIGURE 19 STRUCTURE OF THE HEALTHCARE SECTOR IN SAUDI ARABIA, 2012
  • FIGURE 20 NUMBER OF HOSPITALS IN SAUDI ARABIA BY SUPPLIER, 2012
  • FIGURE 21 MIDDLE EAST/AFRICAN REVENUE FORECAST FOR IMPLANTABLE BIOMATERIALS, 2010-2019 ($ MILLIONS)
Back to Top